My Personal CFO LLC’s Dentsply Sirona XRAY Stock Holding History

My Personal CFO LLC’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7	Closed	-$223	–	856
2022 Q4	$223	Buy	+7	New	+$211	﹤0.01%	885

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

My Personal CFO LLC's XRAY Position: Q1 2023 in Review

My Personal CFO LLC sold out of Dentsply Sirona (XRAY) in Q1 2023, closing a stake of 7 shares — an estimated $223 sold.

My Personal CFO LLC first reported a position in XRAY in Q4 2022 and held it in 1 quarter. The position peaked at $223 in Q4 2022. 453 funds tracked by Wall St. Rank hold XRAY as of Q1 2023.

My Personal CFO LLC reported no remaining Dentsply Sirona position as of Q1 2023 after selling out during the quarter.
My Personal CFO LLC sold 7 Dentsply Sirona shares in Q1 2023, an estimated $223.
My Personal CFO LLC first reported a position in Dentsply Sirona in Q4 2022 and held it in 1 quarter.
My Personal CFO LLC's Dentsply Sirona position peaked at $223 in Q4 2022.
453 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2023.

Based on My Personal CFO LLC's 13F filing for Q1 2023, filed 21 Apr 2023.